ClinicalTrials.govpublic full text
Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer
hepatocellular cancer, liver cancer, liver neoplasms, liver diseases, digestive system diseases, advanced, mitogen-activated protein kinase (mek) inhibitor, kinase inhibitor, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1032211
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.